| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.632 | 35.853 | 36.923 | 35.030 | 36.788 | 27.772 | 53.335 | 50.500 | 48.800 | 48.967 |
| Total Income - EUR | 31.632 | 35.853 | 36.923 | 35.030 | 36.788 | 27.772 | 53.335 | 50.500 | 48.800 | 48.967 |
| Total Expenses - EUR | 27.268 | 28.938 | 30.586 | 32.234 | 30.131 | 26.699 | 46.010 | 48.005 | 45.279 | 40.863 |
| Gross Profit/Loss - EUR | 4.365 | 6.915 | 6.337 | 2.797 | 6.657 | 1.073 | 7.325 | 2.495 | 3.520 | 8.104 |
| Net Profit/Loss - EUR | 3.416 | 6.556 | 6.025 | 2.498 | 6.327 | 834 | 6.831 | 2.019 | 3.035 | 7.614 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Vioptic Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.800 | 1.425 | 1.051 | 688 | 337 | 331 | 323 | 0 | 0 | 0 |
| Current Assets | 16.742 | 20.424 | 19.545 | 19.014 | 21.453 | 21.767 | 24.254 | 23.788 | 25.794 | 26.797 |
| Inventories | 1.643 | 3.737 | 7.204 | 5.947 | 7.446 | 7.304 | 4.912 | 3.546 | 3.383 | 5.735 |
| Receivables | 11.430 | 13.231 | 11.050 | 11.379 | 11.907 | 11.794 | 12.676 | 17.480 | 18.605 | 16.769 |
| Cash | 3.669 | 3.456 | 1.291 | 1.689 | 2.100 | 2.668 | 6.665 | 2.762 | 3.806 | 4.293 |
| Shareholders Funds | 12.519 | 14.460 | 19.794 | 18.536 | 19.605 | 19.867 | 22.215 | 21.314 | 24.285 | 25.207 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.023 | 7.389 | 801 | 1.166 | 2.185 | 2.230 | 2.363 | 2.474 | 1.509 | 1.590 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Vioptic Med Srl